Applications of 8-Cyclopentyl-1,3-Dipropylxanthine in Industrial Manufacturing

As an established manufacturer, we provide 8-Cyclopentyl-1,3-Dipropylxanthine of consistent purity for advanced applications in multiple industries. Our facility supports pharmaceutical, biotechnology, and diagnostic reagent production sectors with compliant material tailored to demanding process needs. Please find below specific applications validated across international supply chains.

1. Active Pharmaceutical Ingredient (API) Synthesis – Adenosine Receptor Antagonist Drugs

Major pharmaceutical companies utilize our raw material as a core intermediate in the synthesis of selective A₁ and A_2A adenosine receptor antagonist APIs. Many CNS and cardiovascular research pipelines depend on precise control in this segment. We deliver high-purity batches suited to FDA-regulated GMP manufacturing, supporting formulation, scale up, and analytic validation. Our QC protocols guarantee consistent impurity profiles critical for final drug safety and efficacy. R&D and production teams adjust feedstock ratios according to standard reaction molarities and clinical program requirements.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP-NF (U.S. Pharmacopeia – National Formulary) relevant monographs
• European Pharmacopoeia (Ph. Eur.) quality guidelines
• 21 CFR Part 211 (US FDA cGMP for finished pharmaceuticals)

Typical usage ratio

• 0.5–3% w/w relative to total API batch mass, adjusted according to final yield requirements and targeted molecular ratios in synthesis.

Downstream process integration

• Introduced as a key substrate during the condensation or cyclization stages of API synthesis, monitored via HPLC and NMR assay as per GMP batch records.

Final product types

• Oral CNS therapeutics (tablets, capsules)
• Injectable cardiovascular agents
• Clinical trial experimental formulations

2. Research Grade Reference Standard for Pharmacological Studies

Leading academic, biotech, and pharmaceutical R&D facilities purchase our analytical grade material for use as a reference standard in pharmacological profiling, binding assays, and receptor selectivity studies. High-purity lots undergo full spectral verification and are packaged with traceable certificates of analysis, supporting regulatory submissions and scientific publications. Quality attributes and impurity profiles comply with the documentation required for validated reference compounds.

Industry compliance standards

• ISO/IEC 17025 calibration and testing laboratory requirements
• Good Laboratory Practice (GLP, OECD guidelines)
• Analytical method validation per ICH Q2(R1)

Typical usage ratio

• 1–10 μM typical solution concentrations for in vitro research assay, according to protocol and instrument calibration curve.

Downstream process integration

• Dissolved and added directly to biochemical or cell-based screening platforms for antagonist activity assessment, often included in binding curve controls.

Final product types

• Published research datasets
• Validated reference standards for in-house QC libraries
• Lead compound screening results

3. Diagnostic Reagent Component in Biosensor Manufacturing

In vitro diagnostic device manufacturers integrate our compound in the development and calibration of biosensors targeting adenosine or its related metabolites. High chemical stability and reproducible interaction specificity make our product preferred as a functional test reagent. We guarantee full chemical traceability and packaging to minimize cross-contamination in regulated cleanroom environments. Diagnostic kits for metabolic, cardiovascular, and neurological disorders benefit from batch-to-batch reliability.

Industry compliance standards

• ISO 13485:2016 Medical devices — Quality management systems
• IVDR (EU) 2017/746 In Vitro Diagnostic Regulation
• US FDA QSR 21 CFR Part 820 for medical device manufacture

Typical usage ratio

• 0.01–0.2% by reagent kit mass, depending on device sensitivity and specific detection platform design.

Downstream process integration

• Incorporated as an analyte or functionalized ligand during reagent formulation and biosensor electrode coating, followed by QC with LC-MS/MS to ensure purity.

Final product types

• Point-of-care biosensor cartridges
• Clinical diagnostic reagent kits
• Laboratory standard solutions for device calibration

4. Chemical Probe for Signal Transduction Studies in Cell Biology

Biotechnology and academic laboratories deploy our xanthine-based structure as a chemical probe to investigate adenosine-receptor mediated pathways and second messenger signaling in target cells. The unique cyclopentyl and dipropyl substitution patterns deliver high receptor selectivity, crucial for dissecting signal-related mechanisms. Our batches meet the low-endotoxin and cell-culture grade requirements, supporting both short-term experiments and longer bioassays without off-target interference.

Industry compliance standards

• ISO 9001:2015 for chemical manufacture
• GLP documentation requirements for traceability
• Cell culture quality assessment: mycoplasma-free certificates

Typical usage ratio

• Typically used at 100 nM to 10 μM in media or assay buffer, titrated based on receptor density and study endpoints.

Downstream process integration

• Solubilized and added during cell treatment protocols to modulate responses in in vitro functional assays; strictly batch-logged for reproducibility.

Final product types

• Preclinical mechanistic research findings
• Signal transduction assay kits
• Data supporting biologic drug development